A Compound Heterozygous Pathogenic Variant in B4GALNT1 Is Associated With Axonal Charcot-Marie-Tooth Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Pathogenic variants in B4GALNT1 have been reported to cause hereditary spastic paraplegia 26. This study has revealed that a novel compound heterozygous pathogenic variant in B4GALNT1 is associated with axonal Charcot-Marie-Tooth disease (CMT). Methods Whole-exome sequencing (WES) was used to identify the causative factors and characterize the clinical features of a Korean family with sensorimotor polyneuropathy. Functional assessment of the mutant genes was performed using a motor neuron cell line. Results The WES revealed a compound heterozygous pathogenic variant (c.128dupC and c.451G>A) in B4GALNT1 as the causative of the present patient, a 53-year-old male who presented with axonal sensorimotor polyneuropathy and cognitive impairment without spasticity. The electrodiagnostic study showed axonal sensorimotor polyneuropathy. B4GALNT1 was critical to the proliferation of motor neuron cells. The compensation assay revealed that the pathogenic variants might affect the enzymatic activity of B4GALNT1. Conclusions This study is the first to identify a case of autosomal recessive axonal CMT associated with a compound heterozygous pathogenic variant in B4GALNT1. This finding expands the clinical and genetic spectra of peripheral neuropathy.
Abstract
Background and Purpose Pathogenic variants in B4GALNT1 have been reported to cause hereditary spastic paraplegia 26. This study has revealed that a novel compound heterozygous pathogenic variant in B4GALNT1 is associated with axonal Charcot-Marie-Tooth disease (CMT). Methods Whole-exome sequencing (WES) was used to identify the causative factors and characterize the clinical features of a Korean family with sensorimotor polyneuropathy. Functional assessment of the mutant genes was performed using a motor neuron cell line. Results The WES revealed a compound heterozygous pathogenic variant (c.128dupC and c.451G>A) in B4GALNT1 as the causative of the present patient, a 53-year-old male who presented with axonal sensorimotor polyneuropathy and cognitive impairment without spasticity. The electrodiagnostic study showed axonal sensorimotor polyneuropathy. B4GALNT1 was critical to the proliferation of motor neuron cells. The compensation assay revealed that the pathogenic variants might affect the enzymatic activity of B4GALNT1. Conclusions This study is the first to identify a case of autosomal recessive axonal CMT associated with a compound heterozygous pathogenic variant in B4GALNT1. This finding expands the clinical and genetic spectra of peripheral neuropathy.
참고문헌 (46)
- Harding AE, "Genetic aspects of hereditary motor and sensory neuropathy(types I and II)", J Med Genet, 17, pp.329~336 (1980)
- Klein CJ, "Inherited neuropathies : clinical overview and update", Muscle Nerve, 48, pp.604~622 (2013)
- Züchner S, "Mechanisms of disease : a molecular genetic update on hereditary axonal neuropathies", Nat Clin Pract Neurol, 2, pp.45~53 (2006)
- Pareyson D, "Diagnosis, natural history, and management of Charcot-Marie-Tooth disease", Lancet Neurol, 8, pp.654~667 (2009)
- Pareyson D, "Axonal Charcot-Marie-Tooth disease : the fog is only slowly lifting", Neurology, 68, pp.1649~1650 (2007)
- Eggermann K, "Hereditary neuropathies : clinical presentation and genetic panel diagnosis", Dtsch Arztebl Int, 115, pp.91~97 (2018)
- Pipis M, "Next-generation sequencing in Charcot-Marie-Tooth disease : opportunities and challenges", Nat Rev Neurol, 15, pp.644~656 (2019)
- Nagata Y, "Expression cloning of beta 1, 4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides", J Biol Chem, 267, pp.12082~12089 (1992)
- Ruan S, "Analysis of melanoma cells stably transfected with beta 1, 4GalNAc transferase(GM2", GD2 synthase)cDNA : relative glycosyltransferase levels play a dominant role in determining ganglioside expression, 1995, pp.323, 11~18
- Yamashiro S, "Substrate specificity of beta 1, 4-N-acetylgalactosaminyltransferase in vitro and in cDNA-transfected cells. GM2", GD2 synthase efficiently generates asialo-GM2 in certain cells, 1995, pp.270, 6149~6155
- Yu RK, "The role of glycosphingolipid metabolism in the developing brain", J Lipid Res, 50(Suppl), pp.S440~S445 (2009)
- Russo D, "Glycosphingolipid-protein interaction in signal transduction", Int J Mol Sci, 17, pp.1732~ (2016)
- She JQ, "Effect of ganglioside on synaptic plasticity of hippocampus in lead-exposed rats in vivo", Brain Res, 1060, pp.162~169 (2005)
- Ariga T, "Pathogenic role of ganglioside metabolism in neurodegenerative diseases", J Neurosci Res, 92, pp.1227~1242 (2014)
- Ariga T, "Thematic review series : sphingolipids. Role of ganglioside metabolism in the pathogenesis of Alzheimer’s disease—a review", J Lipid Res, 49, pp.1157~1175 (2008)
- Desplats PA, "Glycolipid and ganglioside metabolism imbalances in Hunting-ton’s disease", Neurobiol Dis, 27, pp.265~277 (2007)
- Kolter T, "Sphingolipid metabolism diseases", Biochim Biophys Acta, 1758, pp.2057~2079 (2006)
- Boukhris A, "Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia", Am J Hum Genet, 93, pp.118~123 (2013)
- Harlalka GV, "Mutations in B4GALNT1(GM2 synthase)underlie a new disorder of ganglioside biosynthesis", Brain, 136, pp.3618~3624 (2013)
- Wakil SM, "Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia", Clin Genet, 86, pp.500~501 (2014)
- Birouk N, "Charcot-Marie-Tooth disease type 1A with 17p11. 2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases", Brain, 120, pp.813~823 (1997)
- Shy ME, "Reliability and validity of the CMT neuropathy score as a measure of disability", Neurology, 64, pp.1209~1214 (2005)
- Hong YB, "DGAT2 mutation in a family with autosomal-dominant early-onset axonal Charcot-Marie-Tooth disease", Hum Mutat, 37, pp.473~480 (2016)
- Choi YR, "A novel homozygous MPV17 mutation in two families with axonal sensorimotor polyneuropathy", BMC Neurol, 15, pp.179~ (2015)
- Wilkinson PA, "A new locus for autosomal recessive complicated hereditary spastic paraplegia(SPG26)maps to chromosome 12p11. 1-12q14", J Med Genet, 42, pp.80~82 (2005)
- Rose L, "Homozygous B4GALNT1mutation and biochemical glutaric acidemia type II : a case report", Clin Neurol Neurosurg, 189, pp.105553~ (2020)
- Guelly C, "Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I", Am J Hum Genet, 88, pp.99~105 (2011)
- Rivière JB, "KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2", Am J Hum Genet, 89, pp.219~230 (2011)
- Liu YT, "Extended phenotypic spectrum of KIF5A mutations : from spastic paraplegia to axonal neuropathy", Neurology, 83, pp.612~619 (2014)
- Souza PVS, "Early-onset axonal Charcot-Marie-Tooth disease due to SACS mutation", Neuromuscul Disord, 28, pp.169~172 (2018)
- Montecchiani C, "ALS5", SPG11, Brain, pp.2016, 139[DOI]
- Tsai PC, "A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function", Neurology, 83, pp.903~912 (2014)
- Sohn H, "Ganglioside GM3 is involved in neuronal cell death", FASEB J, 20, pp.1248~1250 (2006)
- Itokazu Y, "Gangliosides in nerve cell specification", Prog Mol Biol Transl Sci, 156, pp.241~263 (2018)
- Zitman FM, "Neuromuscular synaptic transmission in aged ganglioside-deficient mice", Neurobiol Aging, 32, pp.157~167 (2011)
- Ando S, "Gangliosides and sialylcholesterol as modulators of synaptic functions", Ann N Y Acad Sci, 845, pp.232~239 (1998)
- Walkley SU, "GM2 ganglioside as a regulator of pyramidal neuron dendritogenesis", Ann N Y Acad Sci, 845, pp.188~199 (1998)
- Vance JE, "Lipid imbalance in the neurological disorder, Niemann-Pick C disease", FEBS Lett, 580, pp.5518~5524 (2006)
- Dawkins JL, "Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I", Nat Genet, 27, pp.309~312 (2001)
- Rotthier A, "Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I", Am J Hum Genet, 87, pp.513~522 (2010)
- Schwartz NU, "Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F", FASEB J, 32, pp.1716~1728 (2018)
- Takamiya K, "Mice with disrupted GM2", GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system, 1996, pp.93, 10662~10667
- Yao D, "Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice", J Neurosci, 34, pp.880~891 (2014)
- Dad R, "Structural annotation of beta-1, 4-N-acetyl galactosaminyltransferase 1(B4GALNT1)causing hereditary spastic paraplegia 26", Gene, 626, pp.258~263 (2017)
- Bhuiyan RH, "Loss of enzyme activity in mutated B4GALNT1 gene products in patients with hereditary spastic paraplegia results in relatively mild neurological disorders : similarity with phenotypes of B4galnt1 knockout mice", Neuroscience, 397, pp.94~106 (2019)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)